Ankylosing spondylitis Trials in Seoul, South Korea
Conditions / Ankylosing spondylitis / Seoul, South Korea
Ankylosing spondylitis has been the subject of sustained clinical investigation across multiple research sites.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04156620 | Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA | COMPLETED | PHASE3 |
| NCT03259074 | Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) | COMPLETED | PHASE3 |
| NCT00576706 | PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity | COMPLETED | PHASE3 |
| NCT01694264 | Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα | TERMINATED | PHASE3 |
| NCT03502616 | Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) | COMPLETED | PHASE3 |
| NCT01965132 | Korean College of Rheumatology Biologics and Targeted Therapy Registry | RECRUITING | — |
| NCT01786668 | Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis | COMPLETED | PHASE2 |
| NCT01083121 | Surveillance of Humira Injection in Korean Patients | COMPLETED | — |
| NCT01685905 | The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection | UNKNOWN | — |
| NCT04795141 | ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis | TERMINATED | PHASE2 |